Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Lumos Diagnostics Holdings's Enterprise Value is A$104.20 Mil.
Lumos Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-13.25 Mil. Therefore, Lumos Diagnostics Holdings's EV-to-EBIT ratio for today is -7.87.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Lumos Diagnostics Holdings (ASX:LDX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Lumos Diagnostics Holdings's EV-to-EBIT for today is
Lumos Diagnostics Holdings's current Enterprise Value is A$104.20 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-13.25 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Lumos Diagnostics Holdings's EV-to-EBITDA for today is:
Lumos Diagnostics Holdings's current Enterprise Value is A$104.20 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$-9.51 Mil.
Lumos Diagnostics Holdings's current Enterprise Value is A$104.20 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$18.57 Mil.
Lumos Diagnostics Holdings's current Enterprise Value is A$104.20 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$-3.49 Mil.
Lumos Diagnostics Holdings's current Enterprise Value is A$104.20 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-3.82 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumos Diagnostics Holdings Enterprise Value Related Terms
Lumos Diagnostics Holdings Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:LDX vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Lumos Diagnostics Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumos Diagnostics Holdings Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumos Diagnostics Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Lumos Diagnostics Holdings's Enterprise Value falls into.
Lumos Diagnostics Holdings Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Lumos Diagnostics Holdings's Enterprise Value for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of A$104.20 Mil mean?
Lumos Diagnostics Holdings (ASX:LDX) has a Enterprise Value of A$104.20 Mil as of Jul. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Lumos Diagnostics Holdings and its competitors.
Is Lumos Diagnostics Holdings' Enterprise Value too high?
Lumos Diagnostics Holdings' current Enterprise Value is A$104.20 Mil. Overall, Lumos Diagnostics Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lumos Diagnostics Holdings' Enterprise Value compare to ABT and SYK?
Lumos Diagnostics Holdings' Enterprise Value of A$104.20 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Lumos Diagnostics Holdings and its competitors. Lumos Diagnostics Holdings's current Enterprise Value is A$104.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumos Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lumos Diagnostics Holdings (ASX:LDX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.11 — trading 425% above its estimated fair value. The current Enterprise Value is A$104.20 Mil. Lumos Diagnostics Holdings' overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Lumos Diagnostics Holdings (ASX:LDX), the current Enterprise Value is A$104.20 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lumos Diagnostics Holdings (ASX:LDX) Overvalued in 2026?
Based on GuruFocus' analysis, Lumos Diagnostics Holdings stock appears to be overvalued.
The current stock price of A$0.11 is trading 425% above its estimated GF Value™ of A$0.02.
GuruFocus considers Lumos Diagnostics Holdings to be Significantly Overvalued.
Key valuation signals for ASX:LDX:
Enterprise Value: A$104.20 Mil
GF Value™: A$0.02 vs. price of A$0.11 (425% above fair value)
No single metric tells the full story. See the ASX:LDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services. The Company operates in two geographical regions, the United States and Australia and the majority of revenue is generated from the United States.
31GF Score
Get the complete analysis for ASX:LDX
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:LDX has been successfully added to your 
